Chilton Capital Management LLC reduced its stake in shares of Healthcare Realty Trust Incorporated (NYSE:HR - Free Report) by 8.2% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 698,673 shares of the real estate investment trust's stock after selling 62,070 shares during the quarter. Chilton Capital Management LLC owned approximately 0.20% of Healthcare Realty Trust worth $11,808,000 at the end of the most recent quarter.
A number of other hedge funds have also recently made changes to their positions in the stock. Starboard Value LP bought a new stake in shares of Healthcare Realty Trust in the fourth quarter valued at about $342,110,000. Norges Bank purchased a new stake in shares of Healthcare Realty Trust in the 4th quarter worth approximately $76,825,000. Rush Island Management LP boosted its stake in shares of Healthcare Realty Trust by 21.2% during the fourth quarter. Rush Island Management LP now owns 15,681,440 shares of the real estate investment trust's stock valued at $265,800,000 after purchasing an additional 2,747,848 shares in the last quarter. Deprince Race & Zollo Inc. purchased a new position in Healthcare Realty Trust during the fourth quarter valued at approximately $39,337,000. Finally, Lasalle Investment Management Securities LLC bought a new position in Healthcare Realty Trust in the fourth quarter worth approximately $31,398,000.
Healthcare Realty Trust Trading Down 0.4%
Shares of NYSE:HR traded down $0.06 on Monday, hitting $15.86. 3,629,148 shares of the company were exchanged, compared to its average volume of 3,152,317. The firm has a market capitalization of $5.57 billion, a P/E ratio of -14.55 and a beta of 0.89. Healthcare Realty Trust Incorporated has a 1-year low of $14.09 and a 1-year high of $18.90. The stock's 50 day moving average price is $15.03 and its 200 day moving average price is $15.95.
Healthcare Realty Trust (NYSE:HR - Get Free Report) last released its quarterly earnings data on Thursday, May 1st. The real estate investment trust reported $0.39 earnings per share for the quarter, meeting analysts' consensus estimates of $0.39. The business had revenue of $288.86 million during the quarter, compared to analyst estimates of $297.39 million. Healthcare Realty Trust had a negative return on equity of 7.06% and a negative net margin of 31.32%. The company's revenue was down 9.2% on a year-over-year basis. During the same quarter last year, the business posted $0.39 EPS. On average, equities analysts predict that Healthcare Realty Trust Incorporated will post 1.59 EPS for the current fiscal year.
Healthcare Realty Trust Announces Dividend
The firm also recently announced a quarterly dividend, which was paid on Friday, May 23rd. Shareholders of record on Monday, May 12th were given a $0.31 dividend. The ex-dividend date was Monday, May 12th. This represents a $1.24 dividend on an annualized basis and a yield of 7.82%. Healthcare Realty Trust's dividend payout ratio is currently -113.76%.
Insider Activity at Healthcare Realty Trust
In related news, Director Thomas N. Bohjalian acquired 2,500 shares of the firm's stock in a transaction dated Tuesday, May 13th. The shares were purchased at an average cost of $14.71 per share, for a total transaction of $36,775.00. Following the acquisition, the director owned 56,502 shares in the company, valued at $831,144.42. The trade was a 4.63% increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 0.37% of the stock is currently owned by company insiders.
Analyst Upgrades and Downgrades
Several research firms have recently commented on HR. Wells Fargo & Company reduced their price target on Healthcare Realty Trust from $16.00 to $15.00 and set an "underweight" rating for the company in a research report on Monday, June 2nd. Wedbush decreased their price objective on Healthcare Realty Trust from $18.00 to $16.00 and set a "neutral" rating for the company in a report on Monday, May 5th. JPMorgan Chase & Co. dropped their target price on Healthcare Realty Trust from $18.00 to $17.00 and set a "neutral" rating on the stock in a research note on Thursday, June 26th. Finally, Wall Street Zen lowered Healthcare Realty Trust from a "hold" rating to a "sell" rating in a research report on Saturday, May 31st. Two research analysts have rated the stock with a sell rating and four have given a hold rating to the company's stock. According to MarketBeat.com, the company currently has an average rating of "Hold" and a consensus target price of $16.40.
View Our Latest Report on HR
About Healthcare Realty Trust
(
Free Report)
Healthcare Realty Trust, Inc provides real estate investment services. It owns, leases, manages, acquires, finances, develops, and redevelops income-producing real estate properties associated primarily with the delivery of outpatient healthcare services throughout the United States of America. The company was founded by David R.
Recommended Stories

Before you consider Healthcare Realty Trust, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Healthcare Realty Trust wasn't on the list.
While Healthcare Realty Trust currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.